Adherence to multiple medications prescribed for a chronic disease: A methodological investigation

Journal of Managed Care Pharmacy

Volumn 20, Issue 8, 2014, Pages 815-823

  Basak, Ramsankar ^a   McCaffrey, David J ^b   Bentley, John P ^a   Przybyla, Sarahmona M ^c   West Strum, Donna ^a   Banahan, Benjamin F ^d  

^a St John Fisher College School of Pharmacy ^*  (United States)

^b ST JOHN FISHER COLLEGE   (United States)

^c RESEARCH INSTITUTE ON ADDICTIONS   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; BEHAVIOR; CHRONIC DISEASE; COHORT ANALYSIS; DIABETIC PATIENT; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LIFE TABLE METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PHARMACY; POLYPHARMACY; PREFERRED PROVIDER ORGANIZATION; PRESCRIPTION; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; ALGORITHM; DIABETES MELLITUS; METHODOLOGY; PATIENT CARE; PATIENT DECISION MAKING; FACTUAL DATABASE; INSURANCE; MIDDLE AGED;

CHRONIC DISEASE; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; POLYPHARMACY; RETROSPECTIVE STUDIES;

EID: 84904898548     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.8.815     Document Type: Article

References (16)

1. Leeper SC. Aggressive hypertension management in patients of advancing and advanced age. South Med J. 2005;98(8):805-08.
2. Mustone Alexander L. Desirable therapeutic characteristics of an optimal antihypertensive agent. Drugs. 2006;66(9):1239-52.
3. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
5. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-61.
6. Fairman K, Motheral B. Evaluating medication adherence: which measure is right for your program? J Manag Care Pharm. 2000;6(6):499-504. Available at: http://www.amcp.org/data/jmcp/ce_v6_499-506.pdf.
7. Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009;15(7):457-64.
8. Khanna R, Pace PF, Mahabaleshwarkar R, Basak RS, Datar M, Banahan BF. Medication adherence for chronic diseases among recipients enrolled in a state Medicaid program. Popul Health Manag. 2012;15(5):253-60.
9. Yu AP, Yu YF, Nichol MB. Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes-an application of marginal structural models. Value Health. 2010;13(8):1038-45.
10. Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatr Serv. 2007;58(2):207-12.
11. Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23(5):588-94.
12. Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009;43(1):36-44.
13. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008;46(11):1125-33.
14. MarketScan Research Databases. Truven Health Analytics (formerly Thomson Reuters Healthcare) Inc., Ann Arbor, MI. Available at: https://marketscan.truvenhealth.com/marketscanportal/. Accessed June 21, 2014.
15. Cerner Multum. Lexicon Plus. 2011. Denver, CO.
16. Cohen FJ, Neslusan CA, Conklin JE, Song X. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care. 2003;26(6):1847-51.